Global Depression Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • ID:PD038146
  • July 2019
  • GIR (Global Info Research)
                          

The Global Depression Therapeutics Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.

Antidepressants are used to treat a wide range of mental disorders, including depression, anxiety, and major depressive disorder. Certain neurotransmitters in the brain exist in chemical form such as dopamine and serotonin, which are responsible for maintaining emotional balance such as mood and behavior.

Scope of the Report:
The worldwide market for Depression Therapeutics is expected to grow at a CAGR of roughly 2.2% over the next five years, will reach 14100 million US$ in 2024, from 12400 million US$ in 2019.

This report focuses on the Depression Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

  •     Pfizer, Inc
  •     Eli Lilly and Company
  •     AstraZeneca, Plc
  •     Allergan Plc
  •     GlaxoSmithKline Plc
  •     Intellipharmaceutics International, Inc
  •     Takeda Pharmaceutical Company Limited
  •     H.Lundbeck A/S
  •     Otsuka Holdings Co.,Ltd
  •     Apotex, Inc
  •     Shionogi & Co. Ltd
  •     Zhejiang Hua Hai Pharmaceutical Co., Ltd
  •     Chengdu Kanghong Pharmaceutical Group

Market Segment by Regions, regional analysis covers
  •     North America (United States, Canada and Mexico)
  •     Europe (Germany, France, UK, Russia and Italy)
  •     Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  •     South America (Brazil, Argentina, Colombia etc.)
  •     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
  •     Selective Serotonin Reuptake Inhibitors (SSRIs)
  •     Selective Norepinephrine Reuptake Inhibitors (SNRIs)
  •     Others

Market Segment by Applications, can be divided into
  •     Hospital Pharmacies
  •     Retail Pharmacies
  •     Online Pharmacies

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Depression Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Depression Therapeutics, with price, sales, revenue and global market share of Depression Therapeutics in 2017 and 2018.
Chapter 3, the Depression Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Depression Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Depression Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Depression Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Depression Therapeutics Introduction
    1.2 Market Analysis by Type
        1.2.1 Selective Serotonin Reuptake Inhibitors (SSRIs)
        1.2.2 Selective Norepinephrine Reuptake Inhibitors (SNRIs)
        1.2.3 Others
    1.3 Market Analysis by Applications
        1.3.1 Hospital Pharmacies
        1.3.2 Retail Pharmacies
        1.3.3 Online Pharmacies
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2014-2024)
            1.4.1.2 Canada Market States and Outlook (2014-2024)
            1.4.1.3 Mexico Market States and Outlook (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2014-2024)
            1.4.2.2 France Market States and Outlook (2014-2024)
            1.4.2.3 UK Market States and Outlook (2014-2024)
            1.4.2.4 Russia Market States and Outlook (2014-2024)
            1.4.2.5 Italy Market States and Outlook (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2014-2024)
            1.4.3.2 Japan Market States and Outlook (2014-2024)
            1.4.3.3 Korea Market States and Outlook (2014-2024)
            1.4.3.4 India Market States and Outlook (2014-2024)
            1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2014-2024)
            1.4.4.2 Egypt Market States and Outlook (2014-2024)
            1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
            1.4.4.4 South Africa Market States and Outlook (2014-2024)
            1.4.4.5 Turkey Market States and Outlook (2014-2024)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Pfizer, Inc
        2.1.1 Business Overview
        2.1.2 Depression Therapeutics Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Pfizer, Inc Depression Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.2 Eli Lilly and Company
        2.2.1 Business Overview
        2.2.2 Depression Therapeutics Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Eli Lilly and Company Depression Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.3 AstraZeneca, Plc
        2.3.1 Business Overview
        2.3.2 Depression Therapeutics Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 AstraZeneca, Plc Depression Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.4 Allergan Plc
        2.4.1 Business Overview
        2.4.2 Depression Therapeutics Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Allergan Plc Depression Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.5 GlaxoSmithKline Plc
        2.5.1 Business Overview
        2.5.2 Depression Therapeutics Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 GlaxoSmithKline Plc Depression Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.6 Intellipharmaceutics International, Inc
        2.6.1 Business Overview
        2.6.2 Depression Therapeutics Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Intellipharmaceutics International, Inc Depression Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.7 Takeda Pharmaceutical Company Limited
        2.7.1 Business Overview
        2.7.2 Depression Therapeutics Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Takeda Pharmaceutical Company Limited Depression Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.8 H.Lundbeck A/S
        2.8.1 Business Overview
        2.8.2 Depression Therapeutics Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 H.Lundbeck A/S Depression Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.9 Otsuka Holdings Co.,Ltd
        2.9.1 Business Overview
        2.9.2 Depression Therapeutics Type and Applications
            2.9.2.1 Product A
            2.9.2.2 Product B
        2.9.3 Otsuka Holdings Co.,Ltd Depression Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.10 Apotex, Inc
        2.10.1 Business Overview
        2.10.2 Depression Therapeutics Type and Applications
            2.10.2.1 Product A
            2.10.2.2 Product B
        2.10.3 Apotex, Inc Depression Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.11 Shionogi & Co. Ltd
        2.11.1 Business Overview
        2.11.2 Depression Therapeutics Type and Applications
            2.11.2.1 Product A
            2.11.2.2 Product B
        2.11.3 Shionogi & Co. Ltd Depression Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.12 Zhejiang Hua Hai Pharmaceutical Co., Ltd
        2.12.1 Business Overview
        2.12.2 Depression Therapeutics Type and Applications
            2.12.2.1 Product A
            2.12.2.2 Product B
        2.12.3 Zhejiang Hua Hai Pharmaceutical Co., Ltd Depression Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.13 Chengdu Kanghong Pharmaceutical Group
        2.13.1 Business Overview
        2.13.2 Depression Therapeutics Type and Applications
            2.13.2.1 Product A
            2.13.2.2 Product B
        2.13.3 Chengdu Kanghong Pharmaceutical Group Depression Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Depression Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
    3.1 Global Depression Therapeutics Sales and Market Share by Manufacturer (2017-2018)
    3.2 Global Depression Therapeutics Revenue and Market Share by Manufacturer (2017-2018)
    3.3 Market Concentration Rate
        3.3.1 Top 3 Depression Therapeutics Manufacturer Market Share in 2018
        3.3.2 Top 6 Depression Therapeutics Manufacturer Market Share in 2018
    3.4 Market Competition Trend
4 Global Depression Therapeutics Market Analysis by Regions
    4.1 Global Depression Therapeutics Sales, Revenue and Market Share by Regions
        4.1.1 Global Depression Therapeutics Sales and Market Share by Regions (2014-2019)
        4.1.2 Global Depression Therapeutics Revenue and Market Share by Regions (2014-2019)
    4.2 North America Depression Therapeutics  Sales and Growth Rate (2014-2019)
    4.3 Europe Depression Therapeutics  Sales and Growth Rate (2014-2019)
    4.4 Asia-Pacific Depression Therapeutics  Sales and Growth Rate (2014-2019)
    4.5 South America Depression Therapeutics  Sales and Growth Rate (2014-2019)
    4.6 Middle East and Africa Depression Therapeutics  Sales and Growth Rate (2014-2019)
5 North America Depression Therapeutics by Country
    5.1 North America Depression Therapeutics Sales, Revenue and Market Share by Country
        5.1.1 North America Depression Therapeutics Sales and Market Share by Country (2014-2019)
        5.1.2 North America Depression Therapeutics Revenue and Market Share by Country (2014-2019)
    5.2 United States Depression Therapeutics Sales and Growth Rate (2014-2019)
    5.3 Canada Depression Therapeutics Sales and Growth Rate (2014-2019)
    5.4 Mexico Depression Therapeutics Sales and Growth Rate (2014-2019)
6 Europe Depression Therapeutics by Country
    6.1 Europe Depression Therapeutics Sales, Revenue and Market Share by Country
        6.1.1 Europe Depression Therapeutics Sales and Market Share by Country (2014-2019)
        6.1.2 Europe Depression Therapeutics Revenue and Market Share by Country (2014-2019)
    6.2 Germany Depression Therapeutics Sales and Growth Rate (2014-2019)
    6.3 UK Depression Therapeutics Sales and Growth Rate (2014-2019)
    6.4 France Depression Therapeutics Sales and Growth Rate (2014-2019)
    6.5 Russia Depression Therapeutics Sales and Growth Rate (2014-2019)
    6.6 Italy Depression Therapeutics Sales and Growth Rate (2014-2019)
7 Asia-Pacific Depression Therapeutics by Country
    7.1 Asia-Pacific Depression Therapeutics Sales, Revenue and Market Share by Country
        7.1.1 Asia-Pacific Depression Therapeutics Sales and Market Share by Country (2014-2019)
        7.1.2 Asia-Pacific Depression Therapeutics Revenue and Market Share by Country (2014-2019)
    7.2 China Depression Therapeutics Sales and Growth Rate (2014-2019)
    7.3 Japan Depression Therapeutics Sales and Growth Rate (2014-2019)
    7.4 Korea Depression Therapeutics Sales and Growth Rate (2014-2019)
    7.5 India Depression Therapeutics Sales and Growth Rate (2014-2019)
    7.6 Southeast Asia Depression Therapeutics Sales and Growth Rate (2014-2019)
8 South America Depression Therapeutics by Country
    8.1 South America Depression Therapeutics Sales, Revenue and Market Share by Country
        8.1.1 South America Depression Therapeutics Sales and Market Share by Country (2014-2019)
        8.1.2 South America Depression Therapeutics Revenue and Market Share by Country (2014-2019)
    8.2 Brazil Depression Therapeutics Sales and Growth Rate (2014-2019)
    8.3 Argentina Depression Therapeutics Sales and Growth Rate (2014-2019)
    8.4 Colombia Depression Therapeutics Sales and Growth Rate (2014-2019)
9 Middle East and Africa Depression Therapeutics by Countries
    9.1 Middle East and Africa Depression Therapeutics Sales, Revenue and Market Share by Country
        9.1.1 Middle East and Africa Depression Therapeutics Sales and Market Share by Country (2014-2019)
        9.1.2 Middle East and Africa Depression Therapeutics Revenue and Market Share by Country (2014-2019)
    9.2 Saudi Arabia Depression Therapeutics Sales and Growth Rate (2014-2019)
    9.3 Turkey Depression Therapeutics Sales and Growth Rate (2014-2019)
    9.4 Egypt Depression Therapeutics Sales and Growth Rate (2014-2019)
    9.5 Nigeria Depression Therapeutics Sales and Growth Rate (2014-2019)
    9.6 South Africa Depression Therapeutics Sales and Growth Rate (2014-2019)
10 Global Depression Therapeutics Market Segment by Type
    10.1 Global Depression Therapeutics Sales, Revenue and Market Share by Type (2014-2019)
        10.1.1 Global Depression Therapeutics Sales and Market Share by Type (2014-2019)
        10.1.2 Global Depression Therapeutics Revenue and Market Share by Type (2014-2019)
    10.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Sales Growth and Price
        10.2.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Sales Growth (2014-2019)
        10.2.2 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Price (2014-2019)
    10.3 Selective Norepinephrine Reuptake Inhibitors (SNRIs) Sales Growth and Price
        10.3.1 Global Selective Norepinephrine Reuptake Inhibitors (SNRIs) Sales Growth (2014-2019)
        10.3.2 Global Selective Norepinephrine Reuptake Inhibitors (SNRIs) Price (2014-2019)
    10.4 Others Sales Growth and Price
        10.4.1 Global Others Sales Growth (2014-2019)
        10.4.2 Global Others Price (2014-2019)
11 Global Depression Therapeutics Market Segment by Application
    11.1 Global Depression Therapeutics Sales Market Share by Application (2014-2019)
    11.2 Hospital Pharmacies Sales Growth (2014-2019)
    11.3 Retail Pharmacies Sales Growth (2014-2019)
    11.4 Online Pharmacies Sales Growth (2014-2019)
12 Depression Therapeutics Market Forecast (2019-2024)
    12.1 Global Depression Therapeutics Sales, Revenue and Growth Rate (2019-2024)
    12.2 Depression Therapeutics Market Forecast by Regions (2019-2024)
        12.2.1 North America Depression Therapeutics Market Forecast (2019-2024)
        12.2.2 Europe Depression Therapeutics Market Forecast (2019-2024)
        12.2.3 Asia-Pacific Depression Therapeutics Market Forecast (2019-2024)
        12.2.4 South America Depression Therapeutics Market Forecast (2019-2024)
        12.2.5 Middle East and Africa Depression Therapeutics Market Forecast (2019-2024)
    12.3 Depression Therapeutics Market Forecast by Type (2019-2024)
        12.3.1 Global Depression Therapeutics Sales Forecast by Type (2019-2024)
        12.3.2 Global Depression Therapeutics Market Share Forecast by Type (2019-2024)
    12.4 Depression Therapeutics Market Forecast by Application (2019-2024)
        12.4.1 Global Depression Therapeutics Sales Forecast by Application (2019-2024)
        12.4.2 Global Depression Therapeutics Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

Related Reports
Global Electronic Health Records Market Research Report

The report on the Global Electronic Health Records Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Hyaluronic Acid Viscosupplementation Industry 2016 Market Research Report

The Global Hyaluronic Acid Viscosupplementation Industry 2016 Market Research Report is a professional and in-depth study on the current state of the  read more..


Global Health Care IT Market Size, Status and Forecast 2018-2025

The Global Health Care IT market research report is the study prepared by analysts, which contain a detailed analysis of drivers, restraints, and  read more..


Global Wall Mount Fireplaces Market Insights, Forecast to 2025

Wall Mount Fireplaces Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Population Health Management Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Population Health Management Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Water Distiller Market Insights, Forecast to 2025

Water Distiller Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Health Insurance Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Health Insurance Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Boat First Aid Kits Industry 2016 Market Research Report

The Global Boat First Aid Kits Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Boat First Aid Kits  read more..


Global Facial Aesthetics Market Report 2018-2025

The Global Facial Aesthetics Market report is a recent research added by DecisionDatabases.com, offers critical insight into the market dynamic. This  read more..


Global Vascular Graft Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Vascular Graft Market gives an estimation of the development of the market based on historical studies and also provides  read more..